CEBPB and lip and oral cavity carcinoma: Importantly, Akt notably enhanced the CCAAT/enhancer binding protein (C/EBP) β (C/EBPβ; CEBPB), as evidenced by the increased expression of C/EBPβ after Akt activation in oral cancer cells.